Doctors need to understand absolute versus relative risk reduction with statinsBMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8357 (Published 10 December 2012) Cite this as: BMJ 2012;345:e8357
- Bernard Freudenthal, core medical trainee year 11
- 1Chase Farm Hospital, Enfield EN2 8JL, UK
In this Patient’s Journey, Mustafa Gunaydin presented to various doctors with marked subjective intolerance of statins before later developing myositis.1 It seems extraordinary that his doctors were so committed to continued …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial